Events Archives - Page 38 of 128

1 minute read

Foghorn Therapeutics Announces Clinical Data From Phase 1 Study Of FHD-286 In Metastatic Uveal Melanoma To Be Presented At ESMO Congress

October 13, 8:12 AM

Foghorn® Therapeutics Inc. (NASDAQ:FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that clinical

FHTX

2 minute read

Ardelyx To Present Data Updates For XPHOZAH For Hyperphosphatemia At Kidney Week 2023 November 1-5 In Philadelphia, PA

By Benzinga Newsdesk

October 13, 8:11 AM

Ardelyx, Inc. (NASDAQ:ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced

ARDX

3 minute read

Normalizing & Professionalizing Cannabis With Cresco Labs’ CEO Charlie Bachtell

By Joana Scopel

October 12, 10:35 PM

“Appreciate the opportunity to be here today,” said keynote speaker Charlie Bachtell, co-founder & CEO of Cresco Labs Inc (OTCQX: CRLBF) at the September Benzinga Cannabis Capital Conference panel discussion, moderated by Debra Borchardt, executive edit

CRLBF

3 minute read

Sight Sciences Announces Presentation Of Phase I Results Of The SAHARA Randomized Controlled Clinical Trial Comparing TearCare To Restasis For The Treatment Of Dry Eye Disease At The American Academy Of Optometry Annual Meeting

By Benzinga Newsdesk

October 12, 4:37 PM

Sight Sciences, Inc. (NASDAQ:SGHT) ("Sight Sciences," or the "Company"), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients'

SGHT

5 minute read

Immuneering Presents Preclinical Data Demonstrating Encouraging Anti-Tumor Activity For IMM-1-104 And IMM-6-415 At AACR-NCI-EORTC Conference

By Benzinga Newsdesk

October 12, 4:36 PM

– Expanded benchmarking of IMM-1-104 as a single agent across more than 190 patient-aligned models in humanized 3D-tumor growth assays demonstrated high sensitivity in a wide range of MAPK-driven tumor types, including

IMRX

1 minute read

Rani Therapeutics To Present Abstract On RT-102 At The 2023 Annual Meeting Of The American Society For Bone And Mineral Research

By Benzinga Newsdesk

October 12, 4:35 PM

Rani Therapeutics Holdings, Inc. ("Rani Therapeutics" or "Rani") (NASDAQ:RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it will present an

RANI

1 minute read

Kineta Announces KVA12123 And Anti-CD27 Agonist Antibody Abstracts Accepted For Poster Presentations At Society For Immunotherapy Of Cancer 2023; Shares Halted On Circuit Breaker To The Upside

By Benzinga Newsdesk

October 12, 10:21 AM

Kineta, Inc. (NASDAQ:KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today that two abstracts have been

1 minute read

Events
News

NLS Pharmaceutics Announces Company Update On Strategic Partnerships; Members Of Executive Leadership Team To Discuss Company Update On Strategic Discussions And Timeline Of Phase 3, NLS To Webcast Its Event Friday, October 20 At 11:00 a.m. ET

By Benzinga Newsdesk

October 12, 9:42 AM

Members of Executive Leadership Team to Discuss Company Update on Strategic Discussions and Timeline of Phase 3,NLS to Webcast its Event Friday, October 20 at 11:00am ETZURICH, SWITZERLAND / ACCESSWIRE / October 12, 2023

NLSP

3 minute read

New Data Presented At CHEST 2023 Demonstrate The Clinical Utility Of Veracyte’s Envisia Genomic Classifier For Patients With Interstitial Lung Disease

By Benzinga Newsdesk

October 12, 9:17 AM

Two studies highlight the value of adding Envisia results to standard-of-care procedures for identifying patients at increased risk of progressive diseaseVeracyte, Inc. (NASDAQ:VCYT) today announced that new data

VCYT

2 minute read

Meet Algorand Foundation’s Matt Keller At Benzinga’s Future Of Digital Assets Event

By Murtuza Merchant

October 12, 8:44 AM

Mark your calendars for Benzinga's Future of Digital Assets conference on Nov. 14, where Matt Keller will delve deep into the realm of the decentralized web.

$ALGO